Epizyme, Inc. Collaboration Agreements
12 Contracts & Agreements
- Amended and Restated Collaboration and License Agreement dated as of March 12, 2015, by and between the Registrant and Eisai Co. Ltd (Filed With SEC on February 23, 2021)
- Amendment No. 2 to Collaboration Agreement dated September 17, 2020 by and between the Company and Boehringer Ingelheim International GmbH (Filed With SEC on November 6, 2020)
- Amendment to Collaboration Agreement dated March 10, 2020 by and between the Company and Boehringer Ingelheim International GmbH (Filed With SEC on May 4, 2020)
- Third Amendment to the Companion Diagnostics Agreement dated March 7, 2018 between the Registrant and Eisai Co. Ltd. on the one side and Roche Molecular Systems, Inc. on the other... (Filed With SEC on May 8, 2018)
- AMENDED AND RESTATED COLLABORATION AND LICENSE AGREEMENT by and between EISAICO., LTD. and EPIZYME, INC. (Filed With SEC on March 16, 2015)
- Confidential Materials omitted and filed separately with the Securities andExchange Commission. Double asterisks denote omissions. Amendment to Collaboration and License Agreement (Filed With SEC on January 28, 2014)
- COLLABORATION AND LICENSE AGREEMENT among CELGENE INTERNATIONAL SÀRL, CELGENE CORPORATION and EPIZYME, INC. (Filed With SEC on May 13, 2013)
- COLLABORATION AND LICENSE AGREEMENT by and between EISAI CO., LTD. and EPIZYME, INC. (Filed With SEC on May 13, 2013)
- COLLABORATION AND LICENSE AGREEMENT by and between GLAXO GROUP LIMITED and EPIZYME, INC. (Filed With SEC on May 13, 2013)
- COLLABORATION AND LICENSE AGREEMENT among CELGENE INTERNATIONAL SÀRL, CELGENE CORPORATION and EPIZYME, INC. (Filed With SEC on April 18, 2013)
- COLLABORATION AND LICENSE AGREEMENT by and between EISAI CO., LTD. and EPIZYME, INC. (Filed With SEC on April 18, 2013)
- COLLABORATION AND LICENSE AGREEMENT by and between GLAXO GROUP LIMITED and EPIZYME, INC. (Filed With SEC on April 18, 2013)
